These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37813130)

  • 1. Cytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation.
    Gondi KT; Kaul DR; Gregg KS; Golbus JR; Aaronson KD; Murthy VL; Konerman MC
    J Heart Lung Transplant; 2024 Mar; 43(3):432-441. PubMed ID: 37813130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Change and Predictors of Myocardial Flow Reserve by Positron Emission Tomography for the Evaluation of Cardiac Allograft Vasculopathy Following Heart Transplantation.
    Gondi KT; Hammer Y; Yosef M; Golbus JR; Madamanchi C; Aaronson KD; Murthy VL; Konerman MC
    J Card Fail; 2024 Jul; 30(7):915-925. PubMed ID: 37890655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Myocardial Flow Reserve by Positron Emission Tomography Predicts Cardiovascular Events After Cardiac Transplantation.
    Konerman MC; Lazarus JJ; Weinberg RL; Shah RV; Ghannam M; Hummel SL; Corbett JR; Ficaro EP; Aaronson KD; Colvin MM; Koelling TM; Murthy VL
    Circ Heart Fail; 2018 Jun; 11(6):e004473. PubMed ID: 29891737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of myocardial flow reserve obtained by 82-rubidium positron emission tomography in long-term follow-up after heart transplantation.
    Nelson LM; Christensen TE; Rossing K; Hasbak P; Gustafsson F
    J Nucl Cardiol; 2022 Oct; 29(5):2555-2567. PubMed ID: 34414554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Prognostic and Diagnostic Value of Myocardial Blood Flow and Myocardial Flow Reserve After Cardiac Transplantation.
    Miller RJH; Manabe O; Tamarappoo B; Hayes S; Friedman JD; Slomka PJ; Patel J; Kobashigawa JA; Berman DS
    J Nucl Med; 2020 Feb; 61(2):249-255. PubMed ID: 31451490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic utility of longitudinal quantification of PET myocardial blood flow early post heart transplantation.
    Wiefels C; Almufleh A; Yao J; deKemp RA; Chong AY; Mielniczuk LM; Stadnick E; Davies RA; Beanlands RS; Chih S
    J Nucl Cardiol; 2022 Apr; 29(2):712-723. PubMed ID: 32918246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of late-term progression of cardiac allograft vasculopathy in patients with orthotopic heart transplantation using quantitative cardiac
    Shrestha UM; Sciammarella M; Pampaloni MH; Botvinick EH; Gullberg GT; DeMarco T; Seo Y
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1461-1472. PubMed ID: 33123937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Flow Assessment After Heart Transplantation Using Dynamic Cadmium-Zinc-Telluride Single-Photon Emission Computed Tomography With
    Ko KY; Ko CL; Lee CM; Cheng JS; Wu YW; Hsu RB; Chen YS; Wang SS; Yen RF; Cheng MF
    Circ Cardiovasc Imaging; 2023 Jun; 16(6):e015034. PubMed ID: 37313753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study.
    Chemaly RF; El Haddad L; Winston DJ; Rowley SD; Mulane KM; Chandrasekar P; Avery RK; Hari P; Peggs KS; Kumar D; Nath R; Ljungman P; Mossad SB; Dadwal SS; Blanchard T; Shah DP; Jiang Y; Ariza-Heredia E
    Clin Infect Dis; 2020 Dec; 71(9):2365-2374. PubMed ID: 32076709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events.
    Clerkin KJ; Topkara VK; Farr MA; Jain R; Colombo PC; Restaino S; Sayer G; Castillo M; Lam EY; Chernovolenko M; Yuzefpolskaya M; DeFilippis E; Latif F; Zorn E; Takeda K; Johnson LL; Uriel N; Einstein AJ
    J Am Coll Cardiol; 2022 Oct; 80(17):1617-1628. PubMed ID: 36265957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
    Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
    J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Impaired Myocardial Flow Reserve on
    Feher A; Boutagy NE; Oikonomou EK; Liu YH; Miller EJ; Sinusas AJ; Hinchcliff M
    Circ Cardiovasc Imaging; 2021 Sep; 14(9):e012208. PubMed ID: 34503339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of cardiovascular events using myocardial strain ratio derived from
    Yamamoto A; Nagao M; Kawakubo M; Ando K; Nakao R; Matsuo Y; Sakai A; Kaneko K; Momose M; Sakai S; Yamaguchi J
    Eur Radiol; 2023 Jun; 33(6):3889-3896. PubMed ID: 36562782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Quantitative Metrics From Positron Emission Tomography in Ischemic Heart Failure.
    Benz DC; Kaufmann PA; von Felten E; Benetos G; Rampidis G; Messerli M; Giannopoulos AA; Fuchs TA; Gräni C; Gebhard C; Pazhenkottil AP; Flammer AJ; Kaufmann PA; Buechel RR
    JACC Cardiovasc Imaging; 2021 Feb; 14(2):454-464. PubMed ID: 32771569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
    Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
    BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of late-onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients.
    Ponz de Antonio I; Rodríguez Chaverri A; García Reyne A; Carrasco Antón N; Lora Pablos D; López Medrano F; de Dios S; Jurado A; Folgueira MD; García-Cosio Carmena MD; Arribas Ynsaurriaga F; Aguado JM; Lumbreras C; Delgado Jiménez JF
    Transpl Infect Dis; 2021 Apr; 23(2):e13479. PubMed ID: 32996216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis.
    Klimczak-Tomaniak D; Roest S; Brugts JJ; Caliskan K; Kardys I; Zijlstra F; Constantinescu AA; Voermans JJC; van Kampen JJA; Manintveld OC
    Transplantation; 2020 Jul; 104(7):1508-1518. PubMed ID: 31644496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
    Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: A prospective cohort study.
    Ahmed AI; Al Rifai M; Alahdab F; Saad JM; Han Y; Alfawara MS; Nabi F; Mahmarian JJ; Al-Mallah MH
    Int J Cardiol; 2023 Jan; 371():465-471. PubMed ID: 36096273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.